This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Popadiuk, C. M. Articles by Kao, K. R. Search for Related Content PubMed PubMed Citation Articles by Popadiuk, C. M. Articles by Kao, K. R.

Antisense Suppression of Pygopus2 Results in Growth Arrest of Epithelial Ovarian Cancer

Authors' Affiliations: ¹ Terry Fox Cancer Research Laboratories, Division of Basic Medical Sciences, and Divisions of ² Women's Health and ³ Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada

Requests for reprints: Kenneth R. Kao, Terry Fox Cancer Research Laboratories, Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, Canada A1B 3V6. Phone: 709-777-6860; Fax: 709-777-7391; E-mail: kkao{at}mun.ca.

Purpose: The Pygopus proteins are critical elements of the canonical Wnt/ß-catenin transcriptional complex. In epithelial ovarian cancer, constitutively active Wnt signaling is restricted to one (endometrioid) tumor subtype. The purpose of this study was to determine the level of expression and growth requirements of human Pygopus2 (hPygo2) protein in epithelial ovarian cancer.

Experimental Design: Expression and subcellular localization of hPygo2 was determined in epithelial ovarian cancer cell lines and tumors using Northern blot, immunoblot, and immunofluorescence. Immunohistochemistry was done on 125 archived patient epithelial ovarian cancer tumors representing all epithelial ovarian cancer subtypes. T-cell factor–dependent transcription levels were determined in epithelial ovarian cancer cells using TOPflash/FOPflash in vivo assays. Phosphorothioated antisense oligonucleotides were transfected into cell lines and growth assayed by cell counting, anchorage-independent colony formation on soft agar, and xenografting into severe combined immunodeficient mice.

Results: All six epithelial ovarian cancer cell lines and 82% of the patient samples overexpressed nuclear hPygo2 compared with control cells and benign disease. Depletion of hPygo2 by antisense oligonucleotides in both Wnt-active (TOV-112D) and Wnt-inactive serous (OVCAR-3, SKOV-3) and clear cell (TOV-21G) carcinoma cell lines halted growth, assessed using tissue culture, anchorage-independent, and xenograft assays.

Conclusions: hPygo2 is unexpectedly widely expressed in, and required in the absence of, Wnt signaling for malignant growth of epithelial ovarian cancer, the deadliest gynecologic malignancy. These findings strongly suggest that inhibition of hPygo2 may be of therapeutic benefit for treating this disease.

This article has been cited by other articles:

				P. G.P. Andrews, M. W. Kennedy, C. M. Popadiuk, and K. R. Kao Oncogenic Activation of the Human Pygopus2 Promoter by E74-Like Factor-1 Mol. Cancer Res., February 1, 2008; 6(2): 259 - 266. [Abstract] [Full Text] [PDF]

				N. Song, K. R. Schwab, L. T. Patterson, T. Yamaguchi, X. Lin, S. S. Potter, and R. A. Lang pygopus 2 has a crucial, Wnt pathway-independent function in lens induction Development, May 15, 2007; 134(10): 1873 - 1885. [Abstract] [Full Text] [PDF]